Canine Arthritis Treatment Market

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine?s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.

Canine Arthritis Treatment Market contains market size and forecasts of Canine Arthritis Treatment in Global, including the following market information:

Global Canine Arthritis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Canine Arthritis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-Steroidal Anti-Inflammatory Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Canine Arthritis Treatment include Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma and Dechra Pharmaceuticals Plc. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Canine Arthritis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Canine Arthritis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Canine Arthritis Treatment Market Segment Percentages, by Type, 2021 (%)

Non-Steroidal Anti-Inflammatory Drugs

Opioids

Global Canine Arthritis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Canine Arthritis Treatment Market Segment Percentages, by Application, 2021 (%)

Veterinary Hospitals and Clinics

Drug Stores

E-commerce

Global Canine Arthritis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Canine Arthritis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Canine Arthritis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Canine Arthritis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Elanco (Eli Lilly and Company)

Boehringer Ingelheim

Zoetis Inc

Vetoquinol S.A.

Bayer AG

Aratana Therapeutics Inc

Norbrook Laboratories Limited

VetStem Biopharma

Dechra Pharmaceuticals Plc